ALGN vs CORT
Align Technology vs Corcept Therapeutics Incorporated — AI-powered side-by-side comparison
ALGN
Align Technology
73
Buy
VS
CORT
Corcept Therapeutics Incorporated
56
Watch
| Metric | ALGN | CORT |
|---|
| AI Score |
73
|
56
|
| Price |
$172.86
|
$111.83
|
| P/E Ratio |
30.03×
|
215.12×
|
| ROE |
10.1%
|
15.4%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
66.5%
|
98.3%
|
| Debt / Equity |
0.03×
|
0.01×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
55.1
|
61.4
|
| Beta |
1.653
|
0.455
|
| Expected Upside |
+7.7%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALGN versus CORT.
ALGN leads by 17 points.
ALGN scores 73/100 (Buy) versus CORT at 56/100 (Watch).
ALGN Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
CORT Committee View
67% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — p/e of 223.5 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- P/E of 223.5 is expensive by classic value standards — Value
- Price-to-book of 11.4x prices in significant intangible value — Value
- EPS declining -62.5% YoY despite any revenue growth — Growth